Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Solid-phase synthesis of muramyl dipeptide (MDP) derivatives using a multipin method.

G Liu1, S D Zhang, S Q Xia

  • 1Institute of Pharmacology and Toxicology, Academy of Military Medical Science, Beijing, China. gangliu27@yahoo.com

Bioorganic & Medicinal Chemistry Letters
|July 13, 2000
PubMed
Summary

A novel solid-phase synthesis method enables the creation of diverse muramyl dipeptide derivatives. This approach facilitates rapid drug screening by generating compound libraries through various chemical reactions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Manganese superoxide dismutase alanine-to-valine polymorphism at codon 16 and lung cancer risk.

Journal of the National Cancer Institute·2001
Same author

Discovery of novel p-arylthio cinnamides as antagonists of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction. 4. Structure-activity relationship of substituents on the benzene ring of the cinnamide.

Journal of medicinal chemistry·2001
Same author

New antimitotic agents with activity in multi-drug-resistant cell lines and in vivo efficacy in murine tumor models.

Journal of medicinal chemistry·2001
Same author

Palladium(II)-catalyzed tandem reaction of intramolecular aminopalladation of allenyl N-tosylcarbamates and conjugate addition.

Organic letters·2001
Same author

A biomechanical analysis of unilateral hooked-sulcated external fixator on osteomined tibia.

Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih·2001
Same author

Cloning and characterization of a metal responsive element-containing fragment from the Wilson disease gene locus by junction trapping.

Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih·2001

Area of Science:

  • Organic Chemistry
  • Medicinal Chemistry
  • Synthetic Chemistry

Background:

  • Muramyl dipeptides (MDPs) are essential components of bacterial cell walls with immunomodulatory properties.
  • Developing efficient synthetic routes for MDP derivatives is crucial for exploring their therapeutic potential.
  • Existing methods may lack the versatility to generate diverse structural analogs for comprehensive screening.

Purpose of the Study:

  • To report a novel solid-phase synthetic strategy for muramyl dipeptide derivatives.
  • To establish a versatile platform for generating a diverse library of MDP analogs.
  • To facilitate subsequent drug screening and discovery efforts.

Main Methods:

  • The study employs a solid-phase synthesis approach.

Related Experiment Videos

  • Key reactions include acylation, reductive alkylation, sulfonamide formation, urea formation, N-alkylation, amine addition, and Ugi reactions.
  • These reactions are performed on a solid support to enable library synthesis.
  • Main Results:

    • A robust solid-phase synthetic method for muramyl dipeptide derivatives has been successfully developed.
    • The method allows for the incorporation of diverse chemical functionalities through various reaction types.
    • This facilitates the generation of a large and varied library of MDP analogs.

    Conclusions:

    • The reported solid-phase synthetic method provides an efficient and versatile route to diverse muramyl dipeptide derivatives.
    • This platform is well-suited for generating compound libraries for high-throughput drug screening.
    • The accessibility of novel MDP analogs may accelerate the discovery of new therapeutic agents.